HIV Citations List: November 2022

Literature Citations

1. Design, Synthesis, Docking Study, and Biological Evaluation of 4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carbohydrazide Derivatives as anti-HIV-1 and Antibacterial Agents. Abdollahi, O., A. Mahboubi, Z. Hajimahdi, and A. Zarghi. Iranian Journal of Pharmaceutical Research, 2021. 21(1): e126562. PMID[36060913]. PMCID[PMC9420229].
[PubMed]. HIV_11_2022.

2. Synthesis, Biological Evaluation, and Molecular Modeling Studies of New 8-Methyl-4-oxo-1,4-dihydroquinoline-3-carbohydrazides as Potential anti-HIV Agents. Alemi, M., F. Kamali, R.V. Roudsari, Z. Hajimahdi, and A. Zarghi. Iranian Journal of Pharmaceutical Research, 2021. 21(1): e123962. PMID[36060911]. PMCID[PMC9420234].
[PubMed]. HIV_11_2022.

3. Bioactivities and HPLC Analysis of Secondary Metabolites of a Morphologically Identified Endophytic Aspergillus Fungus Isolated from Mangifera indica. Chigozie, V.U., M.U. Okezie, E.E. Ajaegbu, F.B. Okoye, and C.O. Esimone. Natural Product Research, 2022. 36(22): p. 5884-5888. PMID[36411530].
[PubMed]. HIV_11_2022.

4. Identification of a Novel anti-HIV-1 Protein from Momordica balsamina Leaf Extract. Coleman, M.I., M. Khan, E. Gbodossou, A. Diop, K. DeBarros, H. Duong, V.C. Bond, V. Floyd, K. Kondwani, V. Montgomery Rice, F. Villinger, and M.D. Powell. International Journal of Environmental Research and Public Health, 2022. 19(22): 15227. PMID[36429944]. PMCID[PMC9690441]
[PubMed]. HIV_11_2022.

5. Synthesis and Biological Activity of Potential Antiviral Compounds through 1,3-Dipolar Cycloadditions; Part 1: General Aspects and Reactions of Azides. Faita, G., M. Leusciatti, and P. Quadrelli. Arkivoc, 2022. 2022(Part viii): p. 19-78. ISI[000868478900004].
[WOS]. HIV_11_2022.

6. Identification of Boronate-containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. Feng, D., H. Lin, L. Jiang, Z. Wang, Y. Sun, Z. Zhou, E. Clercq, C. Pannecouque, D. Kang, P. Zhan, and X. Liu. Molecules, 2022. 27(21): 7538. PMID[36364360]. PMCID[PMC9657321].
[PubMed]. HIV_11_2022.

7. Synthesis, Structure-Activity Relationships, and in Vivo Evaluation of Novel C-17 Amine Derivatives Based on GSK3640254 as HIV-1 Maturation Inhibitors with Broad Spectrum Activity. Hartz, R.A., L. Xu, S.Y. Sit, J. Chen, B.L. Venables, Z. Lin, S. Zhang, Z. Li, D. Parker, T.S. Simmons, S. Jenkins, U.M. Hanumegowda, I. Dicker, M. Krystal, N.A. Meanwell, and A. Regueiro-Ren. Journal of Medicinal Chemistry, 2022. 65(23): p. 15935-15966. PMID[36441509].
[PubMed]. HIV_11_2022.

8. The Envelope Proteins from SARS-CoV-2 and SARS-CoV Potently Reduce the Infectivity of Human Immunodeficiency Virus Type 1 (HIV-1). Henke, W., H. Waisner, S.P. Arachchige, M. Kalamvoki, and E. Stephens. Retrovirology, 2022. 19(1): 25. PMID[36403071]. PMCID[PMC9675205].
[PubMed]. HIV_11_2022.

9. Structural Elucidation and Total Synthesis for the Pair of Unprecedented Polypyridines with anti-AChE and HIV-1 Protease Activities from Alangium chinense. Hu, X.Y., S.J. Zhu, X.H. Meng, H.F. Yu, X. Liu, L.Y. Zhang, Y. Wei, C.W. Lei, X. Wei, and Y. Zhou. The Journal of Organic Chemistry, 2022. 87(23): p. 16047-16053. PMID[36354352].
[PubMed]. HIV_11_2022.

10. Design, Synthesis, and Antiviral Activity of the Thiazole Positional Isomers of a Potent HIV-1 Entry Inhibitor NBD-14270. Kurkin, A.V., F. Curreli, I.R. Iusupov, E.A. Spiridonov, S. Ahmed, P.O. Markov, E.V. Manasova, A. Altieri, and A.K. Debnath. ChemMedChem, 2022. 17(22): e202200344. PMID[36097139].
[PubMed]. HIV_11_2022.

11. Design and Evaluation of Novel HIV-1 Protease Inhibitors Containing Phenols or Polyphenols as P2 Ligands with High Activity against DRV-Resistant HIV-1 Variants. Ma, L., J. Wen, B. Dong, J. Zhou, S. Hu, J. Wang, Y. Wang, M. Zhu, and S. Cen. International Journal of Molecular Sciences, 2022. 23(22): 14178. PMID[36430656]. PMCID[PMC9697080].
[PubMed]. HIV_11_2022.

12. The anti-HIV Activity of Biogenic Silver Nanoparticles Synthesized from Centella asiatica Extracts. Maduray, K., R. Moodley, S. Ramdhani, and R. Parboosing. Journal of Herbal Medicine, 2022. 35: 100592. ISI[000874773200002].
[WOS]. HIV_11_2022.

13. Microbicide Containing Ellagic acid Can Inhibit HIV-1 Infection. Nittayananta, W., A. Promsong, C. Levy, F. Hladik, N. Chaitaveep, S. Ungphaiboon, S. Tewtrakul, and S. Satthakarn. Molecules, 2022. 27(22): 7941. PMID[36432041]. PMCID[PMC9695535].
[PubMed]. HIV_11_2022.

14. Lead Optimization and Avoidance of Metabolic-perturbing Motif Developing Novel Diarylpyrimidines as Potent HIV-1 NNRTIs. Sun, Y., Z. Zhou, D. Feng, L. Jing, F. Zhao, Z. Wang, T. Zhang, H. Lin, H. Song, E. De Clercq, C. Pannecouque, P. Zhan, X. Liu, and D. Kang. Journal of Medicinal Chemistry, 2022. 65(23): p. 15608-15626. PMID[36411036].
[PubMed]. HIV_11_2022.

15. Tigliane-type Diterpene esters from the Fruits of Shirakiopsis indica and Their anti-HIV Activity. Tanaka, N., S. Takahashi, Y. Yoshino, M. Nakatani, F.A. Ahmed, G.M. Hossain, C.H. Chen, K.H. Lee, and Y. Kashiwada. Journal of Natural Products, 2022. 85(11): p. 2687-2693. PMID[36378070].
[PubMed]. HIV_11_2022.

16. Hybrids of Small CD4 Mimics and gp41-Related Peptides as Dual-target HIV Entry Inhibitors. Wang, R., K. Tsuji, T. Kobayakawa, Y. Liu, K. Yoshimura, S. Matsushita, S. Harada, and H. Tamamura. Bioorganic & Medicinal Chemistry, 2022. 76: 117083. PMID[36403413].
[PubMed]. HIV_11_2022.

17. Identification of Novel Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Exploring the Primer Grip Region. Zhang, T., Z. Zhou, F. Zhao, Z. Sang, E. De Clercq, C. Pannecouque, D. Kang, P. Zhan, and X. Liu. Pharmaceuticals, 2022. 15(11): 1438. PMID[36422568]. PMCID[PMC9697031].
[PubMed]. HIV_11_2022.

18. Design, Synthesis, and Mechanistic Study of 2-Pyridone-bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators. Zhang, X., L. Sun, S. Xu, X. Shao, Z. Li, D. Ding, X. Jiang, S. Zhao, S. Cocklin, E. Clercq, C. Pannecouque, A. Dick, X. Liu, and P. Zhan. Molecules, 2022. 27(21): 7640. PMID[36364467]. PMCID[PMC9658817].
[PubMed]. HIV_11_2022.

19. Bioactive Isopimarane and 3,4-Seco Isopimarane Diterpenoids from Isodon amethystoides. Zhao, C., L. Zhou, W. Xie, L. Zhao, C. Zhang, K. He, J. Ye, J. Zhang, L. Pan, J. Zou, and H. Zhang. BMC Chemistry, 2022. 16(1): 96. PMID[36372888]. PMCID[PMC9661758].
[PubMed]. HIV_11_2022.

20. Biosynthesis of Rumbrins and Inspiration for Discovery of HIV Inhibitors. Zhong, B., J. Wan, C. Shang, J. Wen, Y. Wang, J. Bai, S. Cen, and Y. Hu. Acta Pharmaceutica Sinica B, 2022. 12(11): p. 4193-4203. PMID[36386473]. PMCID[PMC9643285].
[PubMed]. HIV_11_2022.

Patent Citations

This month, no relevant HIV patents were identified.